Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, gives counseling points that pharmacists should provide to diabetic patients.

Latest News

Allison Gilchrist, Associate Editor
The 340B Program “mega-guidance” recently released by the Health Resources Services Administration (HRSA) sets stricter standards for contract pharmacy use.
Jeannette Y. Wick, RPh, MBA, FASCP
It can be hard to motivate those who need the flu vaccine the most.
What Pharmacists Need to Know About HRSA Audits
Chris Hatwig, MS, FASHP of Apexus discusses what health-system pharmacists need to know about the potential for HRSA audits to review 340B program compliance requirements.
Meghan Ross, Associate Editor
All US states now permit electronic prescribing of controlled substances, with Missouri’s recent formal authorization making it the final state to do so.
Counseling Points Pharmacists Can Provide to Patients on COPD Medications
Kimberly Henderson, MD, JD, medical director for the Health Systems Alliance at CVS Health and regional medical director for MinuteClinic, discusses some counseling points pharmacists can provide to patients on COPD medications.
Behavioral Patterns that Contribute to a Patient's Propensity to Be More or Less Adherent
Bruce Berger, PhD, president of Berger Consulting LLC, discusses the behavioral patterns that contribute to a patient’s propensity to be more or less adherent to their medications.
Trends in State Protocols Regarding a Pharmacist's Ability to Dispense Smoking Cessation Products
Lisa Kroon, PharmD, CDE, professor and department chairperson of clinical pharmacy at University of California, San Francisco, School of Pharmacy, talks about some current trends in state protocols related to pharmacists' abilities to dispense smoking cessation products.
Split Billing Software and Contract Pharmacy 340B Records
Chris Hatwig, MS, FASHP of Apexus discusses how split billing software helps to keep contract pharmacies organized with respect to 340B requirements.
Factors That Contribute to a Patient's Adherence During Care Transitions
Eric A Wright, PharmD, MPH, investigator I for Geisinger Health Research, discusses the biggest factors that play a role in determining the likelihood that a patient will remain adherent to medications during care transitions.
Krystle Vermes
A generic equivalent to Bristol-Myers Squibb’s entecavir (Baraclude) hepatitis B treatment has been approved by the FDA.

Trending Now

Pharmacist Education

Educated Patient

If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Early detection and treatment are key to protecting eyesight.
Previous TabNext Tab
Strategic Alliance Partners
Latest Issues